Wellnex Life Limited (AIM:WNX)

London flag London · Delayed Price · Currency is GBP · Price in GBX
7.25
0.00 (0.00%)
At close: Dec 5, 2025
-76.61%
Market Cap 5.92M
Revenue (ttm) 11.31M
Net Income (ttm) -7.47M
Shares Out n/a
EPS (ttm) -0.26
PE Ratio n/a
Forward PE 13.21
Dividend n/a
Ex-Dividend Date n/a
Volume 6,299
Average Volume 3,177
Open 8.00
Previous Close 7.25
Day's Range 7.00 - 7.00
52-Week Range 7.00 - 31.30
Beta n/a
RSI 0.25
Earnings Date Dec 12, 2025

About Wellnex Life

Wellnex Life Limited, together with its subsidiaries, develops, markets, and sells health and wellness products in Australia, New Zealand, and the United Kingdom. The company offers topical anti-inflammatory creams, sprays, and roll-ons under the Pain Away brand; caffeine energy liquid capsules and multivitamins under the Wakey Wakey brand; sleep aid products under the Nighty Night brand; teeth whitening solutions under the Mr. Bright brand; pain relief capsules under the Wagner Liquigesics brand; medicinal cannabis under the Wellness Life bran... [Read more]

Industry Packaged Foods
Founded 2011
Country Australia
Stock Exchange London Stock Exchange AIM
Ticker Symbol WNX
Full Company Profile

Financial Performance

In 2025, Wellnex Life's revenue was 23.63 million, an increase of 40.39% compared to the previous year's 16.83 million. Losses were -15.60 million, 13.6% more than in 2024.

Financial numbers in AUD Financial Statements

News

There is no news available yet.